Use of minoxidil sulfate as an anti-tumor drug
US7705010B2 · kind B2 · utility
1Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2006 |
| Grant date | Apr 27, 2010 |
| Priority date | — |
| Expiry date | Oct 30, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions, methods and kits for the treatment of cancer. ATP-dependent potassium channel agonists, salts thereof, or chemical analogs thereof, for example, minoxidil sulfate, have been found to possess anti-neoplastic properties. Administering minoxidil sulfate may prolong the life of a cancer patient; for example, a patient with a brain tumor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.